State Street SPDR Bloomberg High Yield Bond ETF vs Tempus AI — how do they compare? State Street SPDR Bloomberg High Yield Bond ETF trades at $92.73 (market cap $5.86B), while Tempus AI trades at $70.96 (market cap $12.58B). The key difference: Tempus AI is far larger — about 2.1× State Street SPDR Bloomberg High Yield Bond ETF's market cap, and Tempus AI is trading nearer its 52-week high, State Street SPDR Bloomberg High Yield Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold State Street SPDR Bloomberg High Yield Bond ETF for 60 Days and Tempus AI for 22 Days on average.
| JNK | TEM | |
|---|---|---|
Market Cap | $5.86B | $12.58B |
Volume | 7,780,002 | 7,444,569 |
Sector | Fixed Income | Broad Market / Factor |
52-Week High | $98.02 | $99.28 |
52-Week Low | $92.30 | $41.55 |
Typical Hold Time | 60 Days | 22 Days |
Enterprise Value | — | $13.21B |
Signals from Pluang's Aura AI — not financial advice
JNK trades at $92.76, down 0.13% with a bearish technical outlook. The ETF shows neutral oscillators but bearish moving averages, with key support at $92. Recent dividend distributions of $0.53 provide income, though financial ratios are unavailable. Market sentiment is influenced by rising bond yields and geopolitical tensions affecting high-yield debt markets.
Outlook remains cautious amid elevated Treasury yields and inflation concerns. The high-yield bond sector faces pressure from borrowing costs, though institutional interest persists. Key risks include interest rate volatility and economic slowdown impacting credit quality. Income-focused investors may find value in dividend yield despite market headwinds.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
JNK is a major ETF tracking the Bloomberg High Yield Very Liquid Index. It provides exposure to U.S. dollar-denominated junk bonds with above-average liquidity, featuring 2026 top holdings like EchoStar, Cloud Software Group, and Carnival Corp.
Read more on JNK →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →